Progressive Pulmonary Fibrosis: Improving Recognition, Diagnosis, and Patient Communications
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Overview
TARGET AUDIENCE
This educational activity is intended for pulmonologists, rheumatologists, and other members of the health care team who care for patients with progressive pulmonary fibrosis.
PROGRAM OVERVIEW
This case-based education will focus on improving disease recognition and identifying signs and symptoms of progressive fibrosing ILD. This program will help to improve communication and education of patients with newly diagnosed progressive fibrosing ILDs.
LEARNING OBJECTIVES
Upon completion of this course, the learners should be able to:
- Recognize diseases most commonly associated with progressive pulmonary fibrosis (PPF)
- Identify the signs and symptom of PPF to improve diagnosis in accordance with updated guidelines
- Apply strategies to improve communications with, and education of, patients newly diagnosed with PPF
FACULTY
Vikramjit Khangoora, MD
Pulmonary and Critical Care Medicine Faculty
Advanced Lung Disease and Lung Transplant Program
Inova Fairfax Hospital
Falls Church, VA
Elizabeth Volkmann, MD, MS
Director, UCLA Scleroderma Center
Co-director UCLA CTD-ILD Program
University of California
Los Angeles, CA
PLANNING COMMITTEE
Vikramjit Khangoora, MD
Pulmonary and Critical Care Medicine Faculty
Advanced Lung Disease and Lung Transplant Program
Inova Fairfax Hospital
Falls Church, VA
Elizabeth Volkmann, MD, MS
Director, UCLA Scleroderma Center
Co-director UCLA CTD-ILD Program
University of California
Los Angeles, CA
INSTRUCTIONS FOR PARTICIPATION AND CREDIT
There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 50% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.
Credit fulfillment
- If you are requesting AMA credits, ANCC credits, AAPA credits, or a certificate of participation your certificate will be available for download
TECHNICAL REQUIREMENTS
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox, and Safari browsers.
Additionally, this site and its activities are best viewed using the latest operating system for your device.
ACCREDITED PROVIDER
This activity is provided by The France Foundation.
ACCREDITATION STATEMENT
In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSES
The France Foundation designates this activity for 1.0 contact hours.
PHYSICIAN ASSISTANTS
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until July 17, 2024. PAs should only claim credit commensurate with the extent of their participation.
All other healthcare professionals completing this course will be issued a statement of participation.
DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.
Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.
|
Name of Individual |
Role in Activity |
Name of Commercial Interest(s) |
Nature of Relationship(s) |
Mechanism(s) implemented to resolve conflict of interest |
|
Elizabeth Volkmann, MD, MS
|
Planning Committee Member, Faculty |
|
|
Relationship with Boehringer Ingelheim Pharmaceuticals, Inc. for Non-CE Speakers Bureau ended in December 2022 All final planning decisions concerning content, learning objectives, and evaluation questions were made by the non-conflicted Planning Committee member
Content was reviewed by a non-conflicted member of the planning committee to ensure that it is not commercially biased, was fair-balanced, and is based on scientific evidence and/or clinical reasoning |
|
Erika Fox |
TFF Staff |
No financial relationships |
N/A |
N/A |
|
Heather Tarbox, MPH |
TFF Staff |
No financial relationships |
N/A |
N/A |
|
Meghan Macdonald |
TFF Staff |
No financial relationships |
N/A |
N/A |
|
Patrick Harty, PhD |
TFF Content Reviewer |
No financial relationships |
N/A |
N/A |
|
Vikramjit Khangoora, MD |
Planning Committee Member, Faculty |
No financial relationships |
N/A |
N/A |
DISCLOSURE OF UNLABELED USE
TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
DISCLAIMER
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.
COPYRIGHT INFORMATION
Copyright © 2023 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
- The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
- Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation's prior written permission
PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except when such information is required for reporting purposes to the ACCME.
The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.
Additional information regarding The France Foundation’s Privacy Policy can be viewed at http://www.francefoundation.com/privacy.
CONTACT INFORMATION
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.